Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FATIMA Trial: EGCG and Vitamin D3 for Secondary Prevention of Uterine Fibroids

NCT07647198 is registered in ClinicalTrials.gov with Sheikh Shakhbout Medical City as lead sponsor.

NCT NCT07647198
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07647198 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FATIMA Trial: EGCG and Vitamin D3 for Secondary Prevention of Uterine Fibroids
Lead sponsor
Sheikh Shakhbout Medical City
Phase
Phase 2
Overall status
Recruiting
Start date
August 22, 2026
Completion date
December 22, 2029
Enrollment
240 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

uterine fibroids (leiomyoma)